Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with Type II diabetes

Philip Raskin, E. B. Rappaport, S. T. Cole, Y. Yan, R. Patwardhan, M. I. Freed

Research output: Contribution to journalArticlepeer-review

201 Scopus citations

Fingerprint Dive into the research topics of 'Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with Type II diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences